Co-Author: Wout Aarts – Julius Clinical Research
### @@@ Jungyeon Choi – Julius Clinical ### 1991279###Co-Author######Julius Clinical###Co-Author: Jungyeon Choi – Julius Clinical
### @@@ Debabrata Roy, PhD (he/him/his) – Drug Safety Research Unit ### 1359017###Co-Author###Head of Epidemiology and Research###Drug Safety Research Unit###Co-Author: Debabrata Roy, PhD (he/him/his) – Drug Safety Research Unit
### he/him/his @@@ Catherine Fry, PhD, MMedSci – Drug Safety Research Unit ### 1991145###Co-Author###Epidemiologist###Drug Safety Research Unit###Co-Author: Catherine Fry, PhD, MMedSci – Drug Safety Research Unit
### @@@ Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit ### 1062612###Co-Author###Head of Research###Institute of Pharmacovigilance Sciences, Drug Safety Research Unit###Co-Author: Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit
### she/her/hers @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Anna Girardi, PharmD, PhD – ARS Toscana, Florence ### 1659698###Co-Author######ARS Toscana, Florence###Co-Author: Anna Girardi, PharmD, PhD – ARS Toscana, Florence
### @@@ Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy ### 1359270###Co-Author###Researcher###Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy###Co-Author: Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Carlo Alberto Bissacco – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991144###Co-Author######Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Elena Segundo, n/a – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991143###Co-Author######Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Elena Segundo, n/a – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Co-Author###Associate Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Co-Author: Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Jing Zhao, PhD – University of Oslo ### 1991139###Co-Author###Researcher###University of Oslo###Co-Author: Jing Zhao, PhD – University of Oslo
### @@@ Daniel Weibel, PhD – University Medical Center Utrecht ### 1360562###Co-Author###Assistant Professor###University Medical Center Utrecht###Co-Author: Daniel Weibel, PhD – University Medical Center Utrecht
### @@@ Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Daina Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ David Martin, MD, MPH – Moderna, Inc. ### 1360465###Co-Author###Vice President, Clinical Safety and Risk Management###Moderna, Inc.###Co-Author: David Martin, MD, MPH – Moderna, Inc.
### @@@ Samantha St Laurent – Moderna, Inc. ### 1991173###Co-Author######Moderna, Inc.###Co-Author: Samantha St Laurent – Moderna, Inc.
### @@@ Magalie Emilebacker – Moderna, Inc. ### 1991174###Co-Author######Moderna, Inc.###Co-Author: Magalie Emilebacker – Moderna, Inc.
### @@@ Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062544###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###Co-Author: Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Signe Sørup, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1089981###Co-Author###Clinical specialist###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###Co-Author: Signe Sørup, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### she/her/hers @@@ Brianna M. Goodale, PhD – Julius Clinical Research ### 1991133###Presenting Author###Head of Data Science###Julius Clinical Research###Presenting Author: Brianna M. Goodale, PhD – Julius Clinical Research
###Co-Moderator: Nkuchia M. M'ikanatha, DrPH, MPH – University of Pennsylvania School of Medicine
### @@@ Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc. ### 1359188###Co-Moderator###Senior Director###Infectious Disease Epidemiology, Moderna Therapeutics Inc.###Co-Moderator: Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc.
### he/him/hisCo-Moderator: Priscilla Velentgas, MS, PhD (she/her/hers) – Merck
### she/her/hers @@@ Kathleen M. Andersen, PhD (she/her/hers) – Pfizer ### 1723628###Co-Moderator###Director, Vaccines Real World Evidence###Pfizer###Co-Moderator: Kathleen M. Andersen, PhD (she/her/hers) – Pfizer
### she/her/hersPresenting Author: Mengying Li, PhD, MSPH – IQVIA
### @@@ Megan Farris, MSc – IQVIA ### 1991233###Co-Author######IQVIA###Co-Author: Megan Farris, MSc – IQVIA
### @@@ Sophie Jacobovitz, MPH – IQVIA ### 1991234###Co-Author###Epidemiologist###IQVIA###Co-Author: Sophie Jacobovitz, MPH – IQVIA
### @@@ Laura K. Walsh, MSc – IQVIA Inc ### 1991235###Co-Author###Consultant Epidemiologist###IQVIA Inc###Co-Author: Laura K. Walsh, MSc – IQVIA Inc
### @@@ Shangzhi Gao, ScD – IQVIA ### 1991237###Co-Author###Consultant Epidemiologist###IQVIA###Co-Author: Shangzhi Gao, ScD – IQVIA
### @@@ Sarah Irvin – IQVIA ### 1991238###Co-Author######IQVIA###Co-Author: Sarah Irvin – IQVIA
### @@@ Camelia Graham, PhD, MSPH – IQVIA ### 1991239###Co-Author###Principal, Epidemiology and Drug Safety###IQVIA###Co-Author: Camelia Graham, PhD, MSPH – IQVIA
###Co-Author: Michael K. Stagner – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### @@@ Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1062626###Co-Author###Assistant Professor###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### she/her/hers @@@ Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1360313###Co-Author###Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ David Moeny, MPH (he/him/his) – U.S. Food and Drug Administration ### 1655443###Co-Author###Acting Deputy Director, Office of Pharmacovigilance and Epidemiology###U.S. Food and Drug Administration###Co-Author: David Moeny, MPH (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ Robert Rosofsky – Health Information Systems Consulting ### 1991243###Co-Author######Health Information Systems Consulting###Co-Author: Robert Rosofsky – Health Information Systems Consulting
### @@@ Daniel Kiernan – Harvard Pilgrim Health Care Institute ### 1991244###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Daniel Kiernan – Harvard Pilgrim Health Care Institute
### @@@ Laura A. Shockro, BA – Havard Pilgrim HealthCare Institute ### 1991245###Co-Author###Sr. Project Manager###Havard Pilgrim HealthCare Institute###Co-Author: Laura A. Shockro, BA – Havard Pilgrim HealthCare Institute
### @@@ Alexander Mai, n/a – Harvard Pilgrim Health Care Institute ### 1991246###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Alexander Mai, n/a – Harvard Pilgrim Health Care Institute
### @@@ Jessica E. Pritchard, PhD – Duke University ### 1991247###Co-Author###Research Program Leader###Duke University###Co-Author: Jessica E. Pritchard, PhD – Duke University
### @@@ Steven J. Lippmann, PhD – Duke University ### 1991248###Co-Author###Senior Analyst Programmer###Duke University###Co-Author: Steven J. Lippmann, PhD – Duke University
### @@@ Pratap Adhikari – Duke University ### 1991249###Co-Author###Analyst Programmer II###Duke University###Co-Author: Pratap Adhikari – Duke University
### @@@ Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1991183###Presenting Author###Associate Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###Presenting Author: Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### he/him/his